Alterations in the gut’s microbial population may detect individuals at higher risk for Parkinson’s disease well before symptoms appear, according to new research that also points to potential treatments. Scientists identified distinct microbial patterns that are more evident in those with genetic predispositions to Parkinson’s and even more pronounced in diagnosed cases. This pattern could enable physicians to identify at-risk patients years ahead of noticeable signs, and it implies that improved nutrition and microbiome-altering interventions might prevent or postpone the condition. Professor Anthony Schapira, who leads clinical and movement neurosciences at University College London and directed the study, noted that this marks the initial observation of such a microbial indicator in genetically susceptible individuals without symptoms. The indicator intensifies with disease advancement. Schapira added that similar shifts occur in a minor segment of the general public, potentially elevating their risk. Parkinson’s cases have doubled over the last 25 years, affecting over 8.5 million people worldwide. The illness involves gradual brain deterioration, resulting in tremors, slowed movements, and muscle rigidity. Affected individuals frequently face depression, anxiety, sleep disturbances, memory issues, and balance difficulties. The condition stems from neuron loss in the substantia nigra brain region, causing reduced dopamine levels that contribute to many symptoms. No cure exists, but dopamine-enhancing drugs, physical therapy, and surgical options can provide relief. The University College London researchers examined clinical and stool samples from 271 Parkinson’s patients, 43 genetically at-risk individuals without symptoms, and 150 healthy participants. Over a quarter of gut microbe species, totaling 176, showed differing abundances in Parkinson’s patients compared to healthy controls. These differences were unrelated to medications. A comparable profile appeared in those genetically prone but asymptomatic. The team validated these results using additional data from 638 Parkinson’s cases and 319 healthy individuals from the United Kingdom, South Korea, and Turkey. A small number of healthy people exhibited the microbial pattern, indicating possible disease risk, as reported in Nature Medicine. It remains uncertain if the microbial changes cause Parkinson’s, result from it, or interact both ways, but Schapira suggested that microbiome shifts might influence alpha-synuclein protein production, which contributes to neuron damage. He explained that specific bacteria could trigger gut inflammation, increasing alpha-synuclein, which travels via the vagus nerve from the intestines to the brain and into affected cells. The vagus nerve transmits signals between the brain and key organs. Additional studies and trials are required to clarify gut microbes’ role in Parkinson’s and if microbiome adjustments could protect against it, though dietary shifts might offer benefits. In the research, those with the unusual microbiome profile consumed more processed items and saturated fats instead of fruits, vegetables, fiber-rich foods, fish, and legumes. Claire Bale, associate research director at Parkinson’s UK, stated that the findings bolster evidence of the gut microbiome’s significance in Parkinson’s. She noted that these alterations might emerge in the condition’s earliest phases and their degree could align with progression. Bale highlighted that recent years have shown physical activity’s role in symptom management and possibly slowing advancement, and insights into the gut microbiome provide comparable optimism for dietary changes benefiting those with Parkinson’s.
